Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria

Golkocheva-Markova, Еlitsa; Kevorkyan, Аni; Raycheva, Ralitsa; Ismailova, Chiydem; Yoncheva, Viliana; Tenev, Tencho; Emilova, Radoslava; Grigorova, Lyubomira; Baltadzhiev, Ivan; Komitova, Р.

doi:10.1016/j.bjid.2022.102329

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article4

Preprint1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Hepatitis E virus infection upregulates ING5 expression invitroandvivo

Zhao,

Xia,

et al. 2024

Preprint

View full text Add to dashboard Cite

Hepatitis E virus (HEV) is the major pathogen of viral hepatitis. Immunocompromised individual infected by HEV is prone to chronic hepatitis and increases the risk of hepato-cellular carcinoma (HCC). Inhibitor of growth family member 5 (ING5) is a tumor suppressor gene, is low expressed in cancer tumor or cells. However, the underlying relationship between ING5 and HEV infection is unclear. In the present study acute and chronic HEV animal models were employed to explore the interaction between ING5 and HEV. Notably, the expression of ING5 was significantly increased both in the liver of acute HEV infected BALB/c mice and chronic HEV infected rhesus macaques. In addition, the relationship between HEV infection and ING5 expression was further identified in human hepatoma (HepG-2) cells. In conclusion, HEV infection strongly upregulated ING5 expression in vivo and in vitro, bearing significant implications in further understanding the pathogenic mechanism of HEV infection.

show abstract